Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05551754 · ClinicalTrials.gov registry record · Phase 2
Acute Effects of Ketone Supplement on Responses to Alcohol Challenge in Healthy Volunteers
A Phase 2 study of Alcohol Drinking, sponsored by University of Pennsylvania.
- Active
- Registry status
- Phase 2
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT05551754: Active Phase 2 study of Alcohol Drinking, sponsored by University of Pennsylvania.
NCT05551754 is a Phase 2 study of Alcohol Drinking that is active but no longer recruiting, run by University of Pennsylvania. The registered enrollment target is 10 participants, below the 630-participant average among 85 other Alcohol Drinking trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05551754, a Phase 2 study of Alcohol Drinking, is active but no longer recruiting, sponsored by University of Pennsylvania.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single blinded, randomized trial to evaluate the immediate subjective and objective effects of alcohol after a dose ketone supplement compared to a placebo in 10 health volunteers. Subjects will complete 2 lab visits where they consume a dose of alcohol (based on weight), to bring their breath alcohol concentration to about 0.050%. Participants will randomly receive ketone supplement at one lab and the placebo at the next lab.
Primary Outcome
Change in breath/blood alcohol levels (grams per 210 Liters of breath) in response to ketone supplement verse placebo
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Ketone Supplement
- OTHER Alcohol Beverage
Study Locations (1)
Pennsylvania
- University of Pennsylvania Center for Studies of Addiction - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2022-10-20 |
| Est. Completion | 2027-07 |
| Phase | Phase 2 |
What the registry record for NCT05551754 still lists
NCT05551754 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 630-participant average among 85 other Alcohol Drinking trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Alcohol Drinking appearing as the primary indexed condition, and to 2 interventions - of which Ketone Supplement is the first listed.
NCT05551754 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05551754 about?
NCT05551754 is a clinical study titled "Acute Effects of Ketone Supplement on Responses to Alcohol Challenge in Healthy Volunteers". This is a single blinded, randomized trial to evaluate the immediate subjective and objective effects of alcohol after a dose ketone supplement compared to a placebo in 10 health volunteers. Subjects will complete 2 lab visits where they consume a dose of alcohol (based on weight), to bring their br...
What is the current status of trial NCT05551754?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 10 participants. The study started on 2022-10-20. Estimated completion is 2027-07.
What conditions does trial NCT05551754 study?
This clinical trial studies the following conditions: Alcohol Drinking.
What interventions are being tested in trial NCT05551754?
The interventions under investigation include: Ketone Supplement (DIETARY_SUPPLEMENT), Alcohol Beverage (OTHER).
Who is sponsoring clinical trial NCT05551754?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05551754 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Drinking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05551754's enrollment target sits among peer trials
10 85th of 85 the lowest of 85 other Alcohol Drinking trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alcohol Drinking trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Cannabis' Impact on Alcohol Consumption
RECRUITING · Phase 2
-
Ketone Ester Intervention in Alcohol Use Disorder
RECRUITING · Phase 2
-
Effects Ketone Supplement and Alcohol on Brain Metabolism
RECRUITING · Phase 2
-
Effect of Nutritional Ketosis on Alcohol Metabolism
RECRUITING · Phase 2
-
Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT
RECRUITING · Phase 2
-
Does Propranolol, a Beta Blocker, Attenuate Stress-Induced Drinking?
ACTIVE NOT RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI